Industry Veteran Named CEO of Vigilant Biosciences

New “rinse and spit” screen for oral cancer could reduce disfigurement and save lives. Vigilant Biosciences, Inc., recently announced the appointment of David Barshis as Chief Executive Officer.

Read more »

This Week In Diagnostics

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Read more »

Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure

IM Injections of PLX Cells Causing a Dramatic Recovery of Blood Forming Cells.

Read more »

This Week in Diagnostics

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Read more »

NanoViricides Announces Issuance of a Fundamental Patent in the USA

NanoViricides, Inc. (OTC BB: NNVC) announced that a fundamental patent, on which the nanoviricides® technology is based, is due to be issued in the USA on May 8, 2012. The issuance notification was received from the US Patents and Trademarks Office last week.

Read more »

This Week In Diagnostics

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Read more »

OneMedRadio Discusses Gene Therapy and Diagnostics with Dr. Andrew Senyei

OneMedRadio interviewed, Andrew Senyei, an MD with an interest in individualized DNA sequencing and gene therapy for heart disease.

Read more »

Biovest CEO and Sr. Vice President Discuss Global Marketing of BiovaxID

Biovest International, Inc. (OTCQB: BVTI) announced that Biovest is seeking marketing approval in Canada for BiovaxID®, its personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma.

Read more »

NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device

NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.

Read more »

Brain Resource: Revolutionizing a Common Perception of Depression

Their concept is simple: positive thoughts reduce depression. Train your brain to increase positive thoughts.

Read more »